Next top model

By Elie Dolgin Next top model A mouse lung riddled with tumors after inhaling Cre recombinase. Courtesy of David Dankort David Dankort was 4 years into his postdoc at the University of California, San Francisco, without a single paper to show for his work since his PhD. His first two major projects had failed, and if his third experiment didn’t pan out, he was ready to kiss his academic career goodbye. In a last-ditch effort, Dankort had constructed tra

Written byElie Dolgin
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

David Dankort was 4 years into his postdoc at the University of California, San Francisco, without a single paper to show for his work since his PhD. His first two major projects had failed, and if his third experiment didn’t pan out, he was ready to kiss his academic career goodbye. In a last-ditch effort, Dankort had constructed transgenic mice that could be induced to form cancer by activating a particular enzyme. In early 2005, as part of the final test of the experiment, he sedated his mice, placed a solution containing a virus expressing the enzyme under their noses, and waited a couple of weeks. “I’m waiting, I’m waiting, and I start to think: ‘Am I imagining or are these mice ill?’” Dankort recalls. He weighed the mice, and found that they had lost a few grams. Dankort then dissected the mice and found that their lungs were riddled ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies